Clinical Oncology
Volume 19, Issue 9 , Pages 687-692 , November 2007

Is There a Role for Radiotherapy in Operable Rectal Cancer?

Received 25 April 2007 ,Accepted 18 July 2007.

References 

  1. Colorectal Cancer Collaborative . Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet. 2001;358:1291–1304
  2. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M. Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. J Am Med Assoc. 2000;284:1008–1015
  3. Glimelius B, Isacsson U. Preoperative radiotherapy for rectal cancer — is 5 × 5 Gy a good or a bad schedule?. Acta Oncol. 2001;40:958–967
  4. Glimelius B, Graffman S, Pahlman L, Rimsten A, Wilander E. Preoperative irradiation with high-dose fractionation in adenocarcinoma of the rectum and rectosigmoid. Acta Radiol Oncol. 1982;21:373–379
  5. Swedish Rectal Cancer Trial . Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980–987
  6. Folkesson J, Birgisson H, Pahlman L, Cedermark B, Glimelius B, Gunnarsson U. Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol. 2005;23:5644–5650
  7. Holm T, Singnomklao T, Rutqvist LE, Cedermark B. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials. Cancer. 1996;78:968–976
  8. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol. 2005;23:8697–8705
  9. Peeters KC, van de Velde CJ, Leer JW, et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol. 2005;23:6199–6206
  10. Kollmorgen CF, Meagher AP, Wolff BG, Pemberton JH, Martenson JA, Illstrup DM. The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function. Ann Surg. 1994;220:676–682
  11. Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005;23:1847–1858
  12. Pollack J, Holm T, Cedermark B, et al. Late adverse effects of short-course preoperative radiotherapy in rectal cancer. Br J Surg. 2006;93:1519–1525
  13. Birgisson H, Pahlman L, Gunnarsson U, Glimelius B. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol. 2005;23:6126–6131
  14. Enker WE. Total mesorectal excision — the new golden standard of surgery for rectal cancer. Ann Med. 1997;29:127–133
  15. Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–899
  16. Mackay G, Downey M, Molloy RG, O'Dwyer PJ. Is pre-operative radiotherapy necessary in T-T rectal cancer with TME?. Colorectal Dis. 2006;8:34–36
  17. Simunovic M, Sexton R, Rempel E, Moran BJ, Heald RJ. Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg. 2003;90:999–1003
  18. Wibe A, Rendedal PR, Svensson E, et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg. 2002;89:327–334
  19. Hermanek P, Heald RJ. Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal?. Colorectal Dis. 2004;6:10–14
  20. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638–646
  21. Sebag-Montefiore D, Steele R, Quirke P, et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. ASCO Annual Meeting 2006;24: abstract 3511.
  22. Adam IJ, Martin IG, Finan P, et al. Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet. 1994;344:707–711
  23. Birbeck KF, Macklin CP, Tiffin NJ, et al. Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg. 2002;235:449–457
  24. Mawdsley S, Glynne-Jones R, Grainger J, et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival?. Int J Radiat Oncol Biol Phys. 2005;63:745–752
  25. Sebag-Montefiore D, Hingarani M, Cooper R, Chesser P. Circumferential resection margin status predicts outcome after pre-operative chemoradiation for locally advanced rectal cancer. 2005 Gastrointestinal Cancers Symposium. 2005;Vol. Abstract 193
  26. Quirke P, Sebag-Montefiore D, Steele R, et al. Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. J Clin Oncol. 2006;24:abstract 3512
  27. Nagtegaal ID, van de Velde CJH, van der Worp E, Kapiteijn E, Quirke P, van Krieken JHJM, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729–1734
  28. MERCURY Study Group . Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ. 2006;333:779–782
  29. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg. 2003;90:355–364
  30. Bosset J-F, Calais G, Mineur L, et al. Enhanced tumoricidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results – EORTC 22921. J Clin Oncol. 2005;23:5620–5627
  31. Gerard JP, Bonnetain F, Conroy T, et al. Preoperative (preop) radiotherapy (RT) {+/-} 5 FU/folinic acid (FA) in T3-4 rectal cancers: results of the FFCD 9203 randomized trial. J Clin Oncol (Meeting Abstracts). 2005;23:3504
  32. Cionini L, Manfredi B, Sainato A, et al. Randomised study of post-operative chemotherapy after pre-operative chemoradiation in locally advanced rectal cancer. Preliminary results. Eur J Cancer. 2001;37(Suppl. 6):S300
  33. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731–1740
  34. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol. 2004;72:15–24
  35. Bujko K, Kepka L, Michalski W, Nowacki MP. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection? A systematic review of randomised trials. Radiother Oncol. 2006;80:4–12
  36. Rullier E, Sebag-Montefiore D. Sphincter saving is the primary objective for local treatment of cancer of the lower rectum. Lancet Oncol. 2006;7:775–777

PII: S0936-6555(07)00723-6

doi: 10.1016/j.clon.2007.07.004

Clinical Oncology
Volume 19, Issue 9 , Pages 687-692 , November 2007

Article Tools